Tianjin Minxiang Biomedical Inc.

  • Booth: 2734

MinXiang has advantages in pharmaceutical intermediates and raw materials, especially in the field of anti-virus and hypoglycemic drugs, and our company has the largest product line of adamantine in domestic market, which owned an output of 2,000 tons per year. In addition, our company is the largest supplier for the series of adamantane intermediates and raw materials.